Definition:
The market covers diagnostic imaging devices such as X-ray systems, ultrasound systems, computed tomography scanners, Magnetic resonance imaging (MRT) systems, and related components.
Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.
Company examples: Siemens Healthineers, General Electric, Philips, Fujifilm Holdings. Further information on the key players can be found in the Market Shares boxes.
Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.
Most recent update: Aug 2024
Source: Statista Market Insights
Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.
Most recent update: Mar 2024
Most recent update: Mar 2024
Source: Statista Market Insights
The Diagnostic Imaging Devices market in United Arab Emirates is experiencing steady growth due to customer preferences for advanced medical technology, increasing healthcare expenditure, and favorable government initiatives. Customer preferences in the Diagnostic Imaging Devices market in United Arab Emirates are shifting towards more advanced and sophisticated medical imaging equipment. Patients and healthcare professionals are increasingly demanding high-quality, accurate, and efficient diagnostic imaging devices to aid in the diagnosis and treatment of various medical conditions. This has led to a growing demand for devices such as MRI scanners, CT scanners, ultrasound systems, and X-ray machines that provide detailed and precise imaging results. Trends in the market are driven by the overall growth of the healthcare sector in United Arab Emirates. The country has been investing heavily in healthcare infrastructure and technology to improve the quality of healthcare services. This has resulted in an increased adoption of diagnostic imaging devices by healthcare facilities, including hospitals, clinics, and diagnostic centers. Additionally, the rising prevalence of chronic diseases and the aging population have also contributed to the growth of the market, as these conditions often require regular diagnostic imaging procedures. Local special circumstances in United Arab Emirates, such as the presence of a large expatriate population and a growing medical tourism industry, have also contributed to the development of the Diagnostic Imaging Devices market. The country attracts patients from neighboring countries who seek high-quality healthcare services, including advanced diagnostic imaging procedures. This has created a demand for state-of-the-art imaging devices that can cater to the needs of both local and international patients. Underlying macroeconomic factors, such as increasing healthcare expenditure and favorable government initiatives, have played a significant role in the growth of the Diagnostic Imaging Devices market in United Arab Emirates. The government has been actively promoting the development of the healthcare sector through various initiatives, including the establishment of specialized healthcare zones and the implementation of mandatory health insurance. These initiatives have not only increased access to healthcare services but also encouraged investment in advanced medical technology, including diagnostic imaging devices. In conclusion, the Diagnostic Imaging Devices market in United Arab Emirates is witnessing growth due to customer preferences for advanced technology, increasing healthcare expenditure, and favorable government initiatives. The market is expected to continue growing as the demand for accurate and efficient diagnostic imaging devices remains high.
Most recent update: Aug 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.Modeling approach / Market size:
Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights